Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00003561
What this trial is testing

Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Large-scale testing (Phase 3)Study completedNCT02204644
What this trial is testing

The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML

Who this might be right for
CML, CML-CP,MMR,TKI
Jiangsu Hansoh Pharmaceutical Co., Ltd. 400
Early research (Phase 1)Study completedNCT00098436
What this trial is testing

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

Who this might be right for
Leukemia
Vion Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00103844
What this trial is testing

Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia-Positive Myeloid Leukemia
Bristol-Myers Squibb 150
Early research (Phase 1)Looking for participantsNCT03533816
What this trial is testing

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
University of Kansas Medical Center 38
Testing effectiveness (Phase 2)WithdrawnNCT00594555
What this trial is testing

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia, Blast CrisisAcute Myeloid Leukemia
University of Cincinnati 20
Not applicableStudy completedNCT02981784
What this trial is testing

Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I

Who this might be right for
Leukemia
Hospices Civils de Lyon 184
Not applicableLooking for participantsNCT06684964
What this trial is testing

RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

Who this might be right for
Chronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT01850004
What this trial is testing

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 84
Testing effectiveness (Phase 2)Study completedNCT00004052
What this trial is testing

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT04006847
What this trial is testing

Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Milton S. Hershey Medical Center 1
Not applicableUnknownNCT01295463
What this trial is testing

Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Who this might be right for
Cancer
Institut Català d'Oncologia 96
Not applicableUnknownNCT06301321
What this trial is testing

The Evaluation and Comparison of BCR-ABL p210 mRNA Transcripts (%IS Unit) Results Between Dr. PCR™ BCR-ABL1 Major IS Detection Kit (Optolane) and QXDx™ BCR-ABL %IS Kit (Bio-Rad) in Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myelogenous Leukemia
Siriraj Hospital 80
Early research (Phase 1)Study completedNCT01204164
What this trial is testing

Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Who this might be right for
AMLALLBlast Crisis+2 more
Tragara Pharmaceuticals, Inc. 120
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT00077467
What this trial is testing

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00295971
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaLeukemiaMyelodysplastic Syndromes+1 more
University of California, San Francisco 21
Testing effectiveness (Phase 2)Ended earlyNCT00015847
What this trial is testing

Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 25
Testing effectiveness (Phase 2)UnknownNCT02687425
What this trial is testing

Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Meng Li 20
Testing effectiveness (Phase 2)Study completedNCT00134017
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142
Next Page